A detailed history of First County Bank /Ct/ transactions in Amgen Inc stock. As of the latest transaction made, First County Bank /Ct/ holds 5,053 shares of AMGN stock, worth $1.73 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares
5,053
Previous 5,145 1.79%
Holding current value
$1.73 Million
Previous $1.44 Billion 0.74%
% of portfolio
0.73%
Previous 0.77%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 08, 2025

SELL
$271.18 - $309.22 $24,948 - $28,448
-92 Reduced 1.79%
5,053 $1.43 Billion
Q2 2025

Jul 17, 2025

SELL
$262.28 - $309.85 $129,566 - $153,065
-494 Reduced 8.76%
5,145 $1.44 Billion
Q1 2025

Apr 07, 2025

SELL
$258.59 - $327.36 $81,197 - $102,791
-314 Reduced 5.27%
5,639 $1.76 Billion
Q4 2024

Jan 07, 2025

SELL
$258.78 - $328.31 $136,894 - $173,675
-529 Reduced 8.16%
5,953 $1.55 Billion
Q3 2024

Nov 12, 2024

SELL
$309.38 - $337.38 $285,867 - $311,739
-924 Reduced 12.48%
6,482 $2.09 Billion
Q2 2024

Aug 15, 2024

SELL
$262.75 - $319.31 $130,849 - $159,016
-498 Reduced 6.3%
7,406 $2.31 Billion
Q1 2024

May 14, 2024

SELL
$268.87 - $324.56 $490,956 - $592,646
-1,826 Reduced 18.77%
7,904 $2.25 Billion
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $281,014 - $317,017
-1,099 Reduced 10.15%
9,730 $2.8 Billion
Q3 2023

Nov 07, 2023

SELL
$218.65 - $271.46 $105,389 - $130,843
-482 Reduced 4.26%
10,829 $2.91 Billion
Q2 2023

Jul 18, 2023

BUY
$214.27 - $253.37 $413,326 - $488,750
1,929 Added 20.56%
11,311 $2.51 Billion
Q1 2023

Jul 18, 2023

SELL
$225.79 - $275.2 $162,568 - $198,144
-720 Reduced 7.13%
9,382 $2.27 Billion
Q4 2022

Jul 18, 2023

BUY
$229.03 - $291.01 $2.31 Million - $2.94 Million
10,102 New
10,102 $2.65 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track First County Bank /Ct/ Portfolio

Follow First County Bank /Ct/ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First County Bank /Ct/, based on Form 13F filings with the SEC.

News

Stay updated on First County Bank /Ct/ with notifications on news.